| Author | Cahn, Pedro | |
| Author | Villacian, Jorge | |
| Author | Lazzarin, Adriano | |
| Author | Katlama, Christine | |
| Author | Grinsztejn, Beatriz | |
| Author | Arasteh, Keikawus | |
| Author | López, Paulo | |
| Author | Clumeck, Nathan | |
| Author | Gerstoft, Jan | |
| Author | Stavrianeas, Nikolas | |
| Author | Moreno, Santiago | |
| Author | Antunes, Francisco | |
| Author | Neubacher, Dietmar | |
| Author | Mayers, Douglas | |
| Access date | 2019-01-28T12:06:51Z | |
| Available date | 2019-01-28T12:06:51Z | |
| Document date | 2006 | |
| Citation | CAHN, Pedro et al. Ritonavir-boosted Tipranavir demonstrates superior efficacy to Ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-week results of the RESIST-2 trial. Clinical Infectious Diseases, v. 43, p. 1347-1356, 2006. | pt_BR |
| ISSN | 1058-4838 | pt_BR |
| URI | https://www.arca.fiocruz.br/handle/icict/31319 | |
| Language | eng | pt_BR |
| Publisher | Oxford University Press | pt_BR |
| Rights | restricted access | pt_BR |
| Title | Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-week results of the RESIST-2 trial | pt_BR |
| Type | Article | |
| DOI | 10.1086/508352 | |
| Abstract | Tipranavir, a novel protease inhibitor, has demonstrated antiviral activity against protease inhibitor-resistant human immunodeficiency virus type 1 (HIV-1) isolates. The Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST-2) trial is an ongoing, open-label, phase III trial comparing ritonavir-boosted tipranavir (TPV/r) plus an optimized background regimen with an individually optimized, ritonavir-boosted protease inhibitor in treatment-experienced, HIV-1-infected patients. | pt_BR |
| Affilliation | Fundación Huésped. Buenos Aires, Argentina. | pt_BR |
| Affilliation | Boehringer Ingelheim GmbH. Ingelheim am Rhein, Germany. | pt_BR |
| Affilliation | Vila-Salute San Raffaele University. Milan, Italy. | pt_BR |
| Affilliation | Hôpital de la Pitié-Salpétrière. Paris, France. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Auguste-Viktoria Klinikum. Berlin, Germany. | pt_BR |
| Affilliation | Hospital Juan I Menchaca. Instituto Mexicano del Seguro Social. Guadalajara, JAL, Mexico. | pt_BR |
| Affilliation | Hôpital Universitaire St. Pierre. Bruxelles, Belgium. | pt_BR |
| Affilliation | Rigshospitalet. Copenhagen, Denmark. | pt_BR |
| Affilliation | Andreas Syngros Hospital. Athens, Greece. | pt_BR |
| Affilliation | Hospital Ramón y Cajal. Madrid, Spain. | pt_BR |
| Affilliation | Hospital de Santa Maria. Lisbon, Portugal. | pt_BR |
| Affilliation | Boehringer Ingelheim GmbH and Co. KG. Ingelheim am Rhein, Germany. | pt_BR |
| Affilliation | Boehringer Ingelheim Pharmaceuticals. Ridgefield, CT, USA. | pt_BR |
| Subject | HIV | pt_BR |
| Subject | HIV-infected patients | pt_BR |
| Subject | Ritonavir-boosted | pt_BR |
| Subject | Tipranavir | pt_BR |
| e-ISSN | 1537-6591 | |
| Embargo date | 2028-01-01 | |
